The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitorYucai Wang, Sameer A. Parikh, Asher Chanan‐Khan et al.|Haematologica|2020Cited by 35
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemiaPaul J. Hampel, Sameer A. Parikh, Kari G. Rabe et al.|British Journal of Haematology|2022Cited by 24
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J. Hampel, Sameer A. Parikh, Kari G. Rabe et al.|Blood Cancer Journal|2022Cited by 17
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemiaPaul J. Hampel, Wei Ding, Sameer A. Parikh et al.|Blood Cancer Journal|2021Cited by 12
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J. Hampel, Sameer A. Parikh, Kari G. Rabe et al.|Leukemia|2024Cited by 12